Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191079
Max Phase: Preclinical
Molecular Formula: C46H67N9O12S2
Molecular Weight: 1002.23
Associated Items:
ID: ALA5191079
Max Phase: Preclinical
Molecular Formula: C46H67N9O12S2
Molecular Weight: 1002.23
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2)CSCc2cccc(n2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
Standard InChI: InChI=1S/C46H67N9O12S2/c1-24(2)16-32-40(60)51-34(18-27-11-13-30(58)14-12-27)41(61)49-33(17-25(3)4)42(62)55-38(26(5)57)45(65)54-37(44(64)52-35(19-56)46(66)67)23-69-21-29-9-6-8-28(48-29)20-68-22-36(43(63)50-32)53-39(59)31-10-7-15-47-31/h6,8-9,11-14,24-26,31-38,47,56-58H,7,10,15-23H2,1-5H3,(H,49,61)(H,50,63)(H,51,60)(H,52,64)(H,53,59)(H,54,65)(H,55,62)(H,66,67)/t26-,31+,32+,33+,34+,35+,36+,37+,38+/m1/s1
Standard InChI Key: ISUSQZFGDDMFEG-AMBSUKFJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1002.23 | Molecular Weight (Monoisotopic): 1001.4351 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):